CORT Corcept Therapeutics Incorporated Stock Quote

Your browser is no longer supported. Please, upgrade your browser.

publish chart | save to portfolio | create alert

CORT [NASD]

Corcept Therapeutics Incorporated

Healthcare | Biotechnology | USA

statements

Index	-	P/E	16.72	EPS (ttm)	0.87	Insider Own	3.10%	Shs Outstand	114.58M	Perf Week	-4.29%
Market Cap	1.67B	Forward P/E	20.57	EPS next Y	0.71	Insider Trans	-1.79%	Shs Float	103.16M	Perf Month	14.26%
Income	106.00M	PEG	-	EPS next Q	0.23	Inst Own	78.10%	Short Float	21.42%	Perf Quarter	13.37%
Sales	334.90M	P/S	4.99	EPS this Y	29.10%	Inst Trans	-0.68%	Short Ratio	20.08	Perf Half Y	10.69%
Book/sh	3.57	P/B	4.06	EPS next Y	-23.20%	ROA	27.30%	Target Price	15.50	Perf Year	38.62%
Cash/sh	2.66	P/C	5.44	EPS next 5Y	-	ROE	30.00%	52W Range	9.70 - 17.48	Perf YTD	19.83%
Dividend	-	P/FCF	11.55	EPS past 5Y	34.90%	ROI	24.00%	52W High	-17.45%	Beta	1.13
Dividend %	-	Quick Ratio	10.00	Sales past 5Y	63.10%	Gross Margin	98.20%	52W Low	48.76%	ATR	0.75
Employees	206	Current Ratio	10.10	Sales Q/Q	43.80%	Oper. Margin	38.90%	RSI (14)	54.15	Volatility	5.29% 5.11%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	66.80%	Profit Margin	31.60%	Rel Volume	0.76	Prev Close	14.50
Shortable	Yes	LT Debt/Eq	0.00	Earnings	May 04 AMC	Payout	0.00%	Avg Volume	1.10M	Price	14.43
Recom	2.30	SMA20	-0.20%	SMA50	10.76%	SMA200	9.35%	Volume	371,966	Change	-0.48%

Sep-24-19

Initiated

Jefferies

Buy

$20

Sep-06-19

Initiated

H.C. Wainwright

Buy

$18

Feb-04-19

Downgrade

B. Riley FBR

Buy → Neutral

$22 → $12

Aug-10-18

Reiterated

Stifel

Hold

$20 → $11

May-31-18

Downgrade

Stifel

Buy → Hold

$20

Mar-09-18

Initiated

B. Riley FBR, Inc.

Buy

$30

Aug-31-17

Initiated

Stifel

Buy

$20

Feb-02-17

Initiated

Ladenburg Thalmann

Buy

$14

Apr-21-15

Initiated

FBR Capital

Outperform

$12

Jan-13-14

Downgrade

Stifel

Buy → Hold

Aug-09-13

Downgrade

Ladenburg Thalmann

Buy → Neutral

$3.30

Aug-09-13

Downgrade

Janney

Buy → Neutral

Feb-21-12

Reiterated

JMP Securities

Mkt Outperform

$9 → $11

Jan-06-10

Upgrade

Ladenburg Thalmann

Neutral → Buy

Jul-17-08

Initiated

Rodman & Renshaw

Mkt Outperform

Jun-21-07

Upgrade

Punk, Ziegel & Co

Mkt Perform → Accumulate

Jun-03-20 11:30AM	Why Is Corcept (CORT) Up 8.2% Since Last Earnings Report? Zacks
11:30AM	Has Corcept Therapeutics (CORT) Outpaced Other Medical Stocks This Year? Zacks
Jun-02-20 10:00AM	These 4 Biotech Stocks Are Outperforming Their Peers Here's Why Investor's Business Daily -5.54%
May-18-20 06:23AM	Should You Worry About Corcept Therapeutics Incorporated's (NASDAQ:CORT) CEO Pay? Simply Wall St.
May-17-20 09:06PM	Edited Transcript of CORT earnings conference call or presentation 4-May-20 9:00pm GMT Thomson Reuters StreetEvents
May-14-20 04:05PM	Corcept Therapeutics to Present Data at the American Society of Clinical Oncology Annual Meeting GlobeNewswire
May-13-20 01:16PM	6 Stocks John Hussman Continues to Buy GuruFocus.com
May-12-20 07:45AM	Should You Climb on Board the Corcept Therapeutics Train? Motley Fool
May-10-20 10:46PM	Were Hedge Funds Right About Corcept Therapeutics Incorporated (CORT)? Insider Monkey
May-06-20 06:27PM	Corcept Therapeutics Shows Rising Price Performance With Jump To 85 RS Rating Investor's Business Daily
May-05-20 02:50PM	Corcept (CORT) Q1 Earnings Top Estimates, Revenues Rise Y/Y Zacks
08:31AM	New Strong Buy Stocks for May 5th Zacks
01:02AM	Corcept Therapeutics Incorporated (CORT) Q1 2020 Earnings Call Transcript Motley Fool
May-04-20 07:05PM	Corcept Therapeutics (CORT) Tops Q1 Earnings and Revenue Estimates Zacks
04:05PM	Corcept Therapeutics Announces First Quarter 2020 Financial Results And Provides Corporate Update GlobeNewswire
Apr-27-20 04:05PM	Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call GlobeNewswire
12:00PM	Are You Looking for a Top Momentum Pick? Why Corcept Therapeutics (CORT) is a Great Choice Zacks
Apr-22-20 06:43AM	Should You Be Adding Corcept Therapeutics (NASDAQ:CORT) To Your Watchlist Today? Simply Wall St.
Apr-13-20 08:31AM	Corcept Therapeutics' Shares March Higher, Can It Continue? Zacks
Apr-02-20 09:51AM	Why You Shouldn't Bet Against Corcept Therapeutics (CORT) Stock Zacks
Apr-01-20 08:30AM	CORCEPT THERAPEUTICS PUBLISHES ABSTRACT IN THE JOURNAL OF THE ENDOCRINE SOCIETY GlobeNewswire
Mar-26-20 12:06PM	Update: Corcept Therapeutics (NASDAQ:CORT) Stock Gained 88% In The Last Five Years Simply Wall St. +6.59%
Mar-21-20 11:30AM	Corcept (CORT) Down 24.9% Since Last Earnings Report: Can It Rebound? Zacks
Mar-12-20 08:30AM	Corcept Therapeutics Appoints Gregg Alton to Board of Directors GlobeNewswire
Feb-25-20 06:22AM	An Intrinsic Calculation For Corcept Therapeutics Incorporated (NASDAQ:CORT) Suggests It's 25% Undervalued Simply Wall St.
Feb-24-20 12:41PM	Shareholder Alert: Robbins LLP Is Investigating the Officers and Directors of Corcept Therapeutics Incorporated (CORT) Business Wire
Feb-21-20 02:25PM	Corcept (CORT) Q4 Earnings In-Line with Estimates, Up Y/Y Zacks
Feb-20-20 06:15PM	Corcept Therapeutics (CORT) Meets Q4 Earnings Estimates Zacks
04:05PM	Corcept Therapeutics Announces Fourth Quarter And Full-Year 2019 Audited Financial Results And Provides Corporate Update GlobeNewswire
Feb-19-20 12:10PM	Why Corcept (CORT) Could Beat Earnings Estimates Again Zacks
Feb-18-20 11:04AM	What's in Store for Corcept (CORT) This Earnings Season? Zacks
Feb-17-20 12:30PM	Corcept Therapeutics (CORT) to Report Q4 Results: What Awaits? Zacks
Feb-13-20 04:05PM	Corcept Therapeutics to Announce Audited Financial Results, Provide Corporate Update and Host Conference Call GlobeNewswire
Jan-30-20 04:06PM	Corcept Therapeutics Announces Fourth Quarter and Full-Year 2019 Preliminary Selected Financial Results; Provides 2020 Revenue Guidance GlobeNewswire
06:45AM	How Corcept Therapeutics Incorporated (NASDAQ:CORT) Can Impact Your Portfolio Volatility Simply Wall St.
Jan-09-20 08:40AM	Tyme Initiates Dosing in Pivotal Pancreatic Cancer Study Zacks
Jan-08-20 10:18AM	Tyme Out-Licenses Cancer Candidate to Eagle Pharma, Stock Up Zacks
Jan-07-20 10:21AM	Soleno (SLNO) Ends Enrollment in Prader-Willi Syndrome Study Zacks
09:51AM	Intrexon's Blood Cancer Drug Gets Orphan Drug Status From FDA Zacks
09:17AM	Catalyst Gives Preliminary Firdapse Estimates & Other Updates Zacks
07:54AM	New Strong Buy Stocks for January 7th Zacks
Dec-31-19 07:49AM	Read This Before Selling Corcept Therapeutics Incorporated (NASDAQ:CORT) Shares Simply Wall St.
Dec-26-19 07:25PM	Shareholder Alert: Robbins LLP Announces Another Complaint Filed Against Corcept Therapeutics Incorporated (CORT) Business Wire
Dec-10-19 10:46AM	Hedge Funds Are Buying Corcept Therapeutics Incorporated (CORT) Insider Monkey
Dec-07-19 11:31AM	Why Is Corcept (CORT) Down 8.9% Since Last Earnings Report? Zacks
Dec-04-19 07:43AM	Why Corcept Therapeutics Incorporated's (NASDAQ:CORT) High P/E Ratio Isn't Necessarily A Bad Thing Simply Wall St.
Nov-20-19 12:55PM	Edited Transcript of CORT earnings conference call or presentation 7-Nov-19 10:00pm GMT Thomson Reuters StreetEvents -22.08%
Nov-19-19 08:51AM	Can The Uptrend Continue for Corcept Therapeutics? Zacks
Nov-14-19 08:52AM	Options Traders Expect Huge Moves in Corcept (CORT) Stock Zacks
Nov-08-19 10:31AM	Corcept (CORT) Earnings Beat in Q3, Korlym Boosts Sales Zacks
Nov-07-19 07:35PM	Corcept Therapeutics (CORT) Surpasses Q3 Earnings and Revenue Estimates Zacks
04:05PM	Corcept Therapeutics Announces Third quarter 2019 Financial Results and provides corporate update GlobeNewswire
Nov-04-19 06:51AM	Is Corcept Therapeutics Incorporated (NASDAQ:CORT) A High Quality Stock To Own? Simply Wall St.
Oct-31-19 04:05PM	Corcept Therapeutics to Announce Third Quarter Financial Results, Provide Corporate Update and Host Conference Call GlobeNewswire
10:33AM	Analysts Estimate Corcept Therapeutics (CORT) to Report a Decline in Earnings: What to Look Out for Zacks
Oct-27-19 02:04PM	Did Hedge Funds Drop The Ball On Corcept Therapeutics Incorporated (CORT) ? Insider Monkey
Oct-14-19 10:10AM	Why Corcept (CORT) is Poised to Beat Earnings Estimates Again Zacks
Oct-09-19 06:11AM	The Corcept Therapeutics (NASDAQ:CORT) Share Price Has Soared 368%, Delighting Many Shareholders Simply Wall St.
Oct-02-19 06:20PM	Shareholder Alert: Robbins Arroyo Announces Another Complaint Filed Against Corcept Therapeutics Incorporated (CORT) Business Wire
Sep-18-19 08:30AM	Corcept Therapeutics Appoints Kimberly Park to Board of Directors GlobeNewswire
Sep-16-19 10:43AM	Corcept Therapeutics Incorporated (NASDAQ:CORT): A Fundamentally Attractive Investment Simply Wall St.
Sep-13-19 01:54PM	5 Health Care Stocks Gurus Are Buying GuruFocus.com
Aug-31-19 09:31AM	Corcept (CORT) Up 15.1% Since Last Earnings Report: Can It Continue? Zacks
Aug-29-19 06:57PM	Edited Transcript of CORT earnings conference call or presentation 1-Aug-19 9:00pm GMT Thomson Reuters StreetEvents
Aug-28-19 04:05PM	Corcept Therapeutics Announces Allowance of Additional Patent Covering the Use of Korlym to Treat Patients With Cushings Syndrome GlobeNewswire
Aug-27-19 01:05PM	Is Corcept Therapeutics Incorporated's (NASDAQ:CORT) CEO Overpaid Relative To Its Peers? Simply Wall St.
Aug-05-19 09:18AM	Corcept's (CORT) Earnings & Revenues Miss Estimates in Q2 Zacks
Aug-03-19 12:18AM	Corcept Therapeutics Incorporated (CORT) Q2 Earnings Call Transcript Motley Fool
Aug-01-19 07:05PM	Corcept Therapeutics (CORT) Q2 Earnings Beat Estimates Zacks
04:05PM	Corcept Therapeutics Announces Second Quarter 2019 Financial Results and Provides Corporate Update GlobeNewswire
08:00AM	Does Corcept Therapeutics Incorporated (NASDAQ:CORT) Have A High Beta? Simply Wall St.
Jul-25-19 04:05PM	Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call GlobeNewswire
Jul-09-19 10:03AM	Can We See Significant Insider Ownership On The Corcept Therapeutics Incorporated (NASDAQ:CORT) Share Register? Simply Wall St.
Jun-19-19 12:41PM	Corcept Therapeutics Incorporated (NASDAQ:CORT): Poised For Long Term Success? Simply Wall St.
Jun-08-19 09:30AM	Corcept (CORT) Down 11.3% Since Last Earnings Report: Can It Rebound? Zacks
Jun-01-19 11:37AM	The Week Ahead In Biotech: ASCO Presentations Pick Up The Pace Benzinga
May-30-19 01:21PM	Is Corcept Therapeutics Incorporated's (NASDAQ:CORT) P/E Ratio Really That Good? Simply Wall St.
May-28-19 08:05AM	Corcept Therapeutics to Present Data from Phase 1/2 Trial of Relacorilant Plus Nab-Paclitaxel in Patients with Solid Tumors at the American Society of Clinical Oncology Annual Meeting GlobeNewswire
May-20-19 07:30AM	Lawsuit for Investors in shares of Corcept Therapeutics Incorporated (NASDAQ: CORT) announced by Shareholders Foundation ACCESSWIRE
May-19-19 10:12PM	Edited Transcript of CORT earnings conference call or presentation 9-May-19 9:00pm GMT Thomson Reuters StreetEvents
May-16-19 10:00PM	Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Corcept, Mobile TeleSystems, Healthcare Services, and American Renal and Encourages Investors to Contact the Firm GlobeNewswire
May-13-19 03:00PM	CRBP, NIO & CORT Deadline Alert - Bronstein, Gewirtz & Grossman, LLC Class Action GlobeNewswire
10:43AM	DEADLINE MONDAY REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Corcept Therapeutics Incorporated and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
09:51AM	CRBP, NIO & CORT Deadline Alert - Bronstein, Gewirtz & Grossman, LLC Class Action ACCESSWIRE
09:30AM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CORT, HCSG, BA and NOK GlobeNewswire
09:21AM	DEADLINE TODAY: Rosen Law Firm Reminds Corcept Therapeutics Incorporated Investors of Important May 13th Deadline in Securities Class Action Lawsuit - CORT GlobeNewswire
May-12-19 10:20AM	INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In NIO, CORT, HCSG or FCHS To Contact The Firm GlobeNewswire
May-10-19 05:30PM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CORT, FSNN and BSX ACCESSWIRE -5.08%
03:50PM	3-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Corcept Therapeutics Incorporated and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
02:25PM	CLASS ACTION UPDATE for CORT, FSNN and MWA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
12:00PM	DEADLINE MONDAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Corcept Therapeutics Incorporated and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire
11:56AM	Corcept Therapeutics Incorporated (CORT) Q1 2019 Earnings Call Transcript Motley Fool
May-09-19 07:25PM	Corcept Therapeutics (CORT) Q1 Earnings Top Estimates Zacks
06:23PM	Corcept: 1Q Earnings Snapshot Associated Press
05:30PM	CLASS ACTION UPDATE for CORT, NIO and BSX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
05:21PM	Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Corcept Therapeutics Incorporated GlobeNewswire
04:05PM	Corcept Therapeutics Announces First Quarter 2019 Financial Results and Provides Corporate Update GlobeNewswire
03:45PM	LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Corcept Therapeutics Incorporated To Contact The Firm ACCESSWIRE
03:29PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT GlobeNewswire
02:10PM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CORT, FSNN and APYX ACCESSWIRE

Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and psychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have failed surgery or are not candidates for surgery. It is developing relacorilant that is in Phase III clinical trial to treat patients with Cushing's syndrome; and Abraxane in combination with relacorilant, which is in Phase II clinical trial to treat patients with serous ovarian tumors, as well as in Phase I/II clinical trial for the treatment of solid tumors. The company is also developing selective cortisol modulator combined with Xtandi that is in open label dose finding trial to treat patients with metastatic castration-resistant prostate cancer; selective cortisol modulator that is in Phase II for the treatment of antipsychotic-induced weight gain; and FKBP5 gene expression assays. Corcept Therapeutics Incorporated was founded in 1998 and is headquartered in Menlo Park, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BAKER G LEONARD JR	Director	May 28	Option Exercise	3.47	30,000	104,100	1,026,838	May 29 04:09 PM
BAKER G LEONARD JR	Director	May 28	Sale	15.70	30,000	471,060	996,838	May 29 04:09 PM
Swisher Daniel N JR	Director	May 22	Option Exercise	6.55	5,000	32,750	5,000	May 27 07:53 PM
MAHONEY DAVID L	Director	May 22	Option Exercise	3.47	38,984	135,274	88,984	May 27 07:48 PM
Swisher Daniel N JR	Director	May 22	Sale	16.10	5,000	80,500	0	May 27 07:53 PM
Robb Gary Charles	Chief Financial Officer	Dec 09	Option Exercise	1.92	30,000	57,600	38,025	Dec 11 04:42 PM
Robb Gary Charles	Chief Financial Officer	Dec 09	Sale	13.73	30,000	412,029	8,025	Dec 11 04:42 PM
WILSON JAMES N	Director	Oct 28	Option Exercise	2.30	284,218	653,701	400,000	Oct 30 05:36 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience